Regeneron Pharmaceuticals, Inc. (BVMF:REGN34)

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 14, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	408,676	474,006	453,222	407,367	367,893	264,799
Market Cap Growth	-13.26%	4.59%	11.26%	10.73%	38.93%	60.48%
Enterprise Value	322,648	377,624	390,193	352,972	319,306	248,149
Last Close Price	65.54	72.57	67.85	62.76	59.14	41.46
PE Ratio	16.75	17.37	23.63	17.76	8.18	14.51
PS Ratio	5.38	5.40	7.12	6.33	4.11	6.00
PB Ratio	2.48	2.61	3.60	3.40	3.52	4.63
P/TBV Ratio	2.59	2.72	3.75	3.54	3.52	4.63
P/FCF Ratio	18.16	20.91	24.10	17.42	10.11	25.45
P/OCF Ratio	15.12	17.34	20.33	15.37	9.32	19.48
EV/Sales Ratio	4.22	4.30	6.13	5.49	3.57	5.62
EV/EBITDA Ratio	13.71	13.19	17.28	12.51	6.18	12.25
EV/EBIT Ratio	15.72	14.73	19.00	13.37	6.37	13.04
EV/FCF Ratio	14.34	16.66	20.75	15.09	8.78	23.85
Debt / Equity Ratio	0.09	0.10	0.11	0.12	0.14	0.25
Debt / EBITDA Ratio	0.62	0.63	0.60	0.52	0.29	0.69
Debt / FCF Ratio	0.64	0.80	0.72	0.63	0.41	1.35
Asset Turnover	0.37	0.40	0.42	0.45	0.76	0.53
Inventory Turnover	2.46	2.51	2.51	2.37	2.74	2.26
Quick Ratio	3.19	3.86	4.82	4.16	2.98	2.86
Current Ratio	4.06	4.73	5.69	5.06	3.56	3.63
Return on Equity (ROE)	15.19%	15.95%	16.26%	20.94%	54.21%	31.77%
Return on Assets (ROA)	6.16%	7.31%	8.49%	11.42%	26.39%	14.33%
Return on Capital (ROIC)	7.27%	8.49%	9.76%	13.31%	31.95%	17.95%
Return on Capital Employed (ROCE)	10.70%	12.30%	14.30%	19.20%	41.80%	25.30%
Earnings Yield	5.97%	5.76%	4.23%	5.63%	12.23%	6.89%
FCF Yield	5.51%	4.78%	4.15%	5.74%	9.89%	3.93%
Buyback Yield / Dilution	4.39%	-1.23%	-0.18%	-1.16%	2.52%	-0.44%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.